Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Miller

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 3, 2015
Exploiting natural killer cells for therapy of melanomaOliver Hölsken, Matthias Miller, Adelheid Cerwenka
Oncoimmunology|June 5, 2013
Toward the next generation of NK cell-based adoptive cancer immunotherapyJing Ni, Matthias Miller, Ana Stojanovic, et al.
Current Pharmaceutical Design|October 29, 2009
Characterization of MHC ligands for peptide based tumor vaccinationFelix Klug, Matthias Miller, Hans-Henning Schmidt, et al.
IEEE Transactions on Visualization and Computer Graphics|October 24, 2023
SkiVis: Visual Exploration and Route Planning in Ski ResortsJulius Rauscher, Raphael Buchmuller, Daniel A Keim, et al.
The Journal of Experimental Medicine|December 5, 2012
Sustained effector function of IL-12/15/18-preactivated NK cells against established tumorsJing Ni, Matthias Miller, Ana Stojanovic, et al.
IEEE Computer Graphics and Applications|July 3, 2019
Visual Analytics of Volunteered Geographic Information: Detection and Investigation of Urban Heat IslandsDaniel Seebacher, Matthias Miller, Tom Polk, et al.
IEEE Transactions on Visualization and Computer Graphics|June 21, 2023
FS/DS: A Theoretical Framework for the Dual Analysis of Feature Space and Data SpaceFrederik L Dennig, Matthias Miller, Daniel A Keim, et al.
Oncoimmunology|October 21, 2016
Highly efficient IL-21 and feeder cell-driven <i>ex vivo</i> expansion of human NK cells with therapeutic activity in a xenograft mouse model of melanomaMarkus Granzin, Ana Stojanovic, Matthias Miller, et al.
European Journal of Immunology|November 7, 2017
KIR downregulation by IL-12/15/18 unleashes human NK cells from KIR/HLA-I inhibition and enhances killing of tumor cellsEva-Maria Ewen, Jens H W Pahl, Matthias Miller, et al.
Oncoimmunology|October 21, 2016
Adoptively transferred natural killer cells maintain long-term antitumor activity by epigenetic imprinting and CD4<sup>+</sup> T cell helpJing Ni, Oliver Hölsken, Matthias Miller, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 3, 2015
Exploiting natural killer cells for therapy of melanomaOliver Hölsken, Matthias Miller, Adelheid Cerwenka
Oncoimmunology|June 5, 2013
Toward the next generation of NK cell-based adoptive cancer immunotherapyJing Ni, Matthias Miller, Ana Stojanovic, et al.
Current Pharmaceutical Design|October 29, 2009
Characterization of MHC ligands for peptide based tumor vaccinationFelix Klug, Matthias Miller, Hans-Henning Schmidt, et al.
IEEE Transactions on Visualization and Computer Graphics|October 24, 2023
SkiVis: Visual Exploration and Route Planning in Ski ResortsJulius Rauscher, Raphael Buchmuller, Daniel A Keim, et al.
The Journal of Experimental Medicine|December 5, 2012
Sustained effector function of IL-12/15/18-preactivated NK cells against established tumorsJing Ni, Matthias Miller, Ana Stojanovic, et al.
IEEE Computer Graphics and Applications|July 3, 2019
Visual Analytics of Volunteered Geographic Information: Detection and Investigation of Urban Heat IslandsDaniel Seebacher, Matthias Miller, Tom Polk, et al.
IEEE Transactions on Visualization and Computer Graphics|June 21, 2023
FS/DS: A Theoretical Framework for the Dual Analysis of Feature Space and Data SpaceFrederik L Dennig, Matthias Miller, Daniel A Keim, et al.
Oncoimmunology|October 21, 2016
Highly efficient IL-21 and feeder cell-driven <i>ex vivo</i> expansion of human NK cells with therapeutic activity in a xenograft mouse model of melanomaMarkus Granzin, Ana Stojanovic, Matthias Miller, et al.
European Journal of Immunology|November 7, 2017
KIR downregulation by IL-12/15/18 unleashes human NK cells from KIR/HLA-I inhibition and enhances killing of tumor cellsEva-Maria Ewen, Jens H W Pahl, Matthias Miller, et al.
Oncoimmunology|October 21, 2016
Adoptively transferred natural killer cells maintain long-term antitumor activity by epigenetic imprinting and CD4<sup>+</sup> T cell helpJing Ni, Oliver Hölsken, Matthias Miller, et al.
Pageof 2